Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 3/2018

06.02.2018 | Original Article

Effect of prior dengue infection on severity and outcome of Japanese encephalitis

verfasst von: A. Verma, A. Jain, C. Kumar, M. Agarwal, R. Kumar

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Japanese encephalitis (JE) virus and dengue virus are closely related flaviviruses but interaction between them is scarcely studied in humans. The objective of this study was to compare the outcome of JE patients who are positive and negative for dengue IgG antibodies. Patients of acute encephalitis syndrome (AES) fulfilling predecided inclusion and exclusion criteria underwent a detailed standardized workup incorporating JE IgM testing in cerebrospinal fluid (CSF) or serum. Dengue IgG in serum was tested in all. Outcomes and clinical features were compared between JE patients who were dengue IgG positive and negative in hospital and after 3 months. A total of 182 patients of JE were enrolled over 3 seasons. After excluding equivocal cases, hospital outcome was compared between 105 dengue IgG-positive and 50 dengue IgG-negative patients. Dengue IgG-positive patients had a significantly better outcome (relative risk 1.4; 95% confidence interval 1.1–1.8). On follow-up after 3 months, again, outcome was significantly better among 95 dengue IgG-positive patient than 47 dengue IgG-negative patients (relative risk 1.3; 95% confidence interval 1.01–1.8). Presence of pre-existing dengue IgG antibodies in JE patients is associated with improved outcomes.
Literatur
1.
Zurück zum Zitat Price WH, Thind IS (1971) Protection against West Nile virus induced by a previous injection with dengue virus. Am J Epidemiol 94:596–606CrossRefPubMed Price WH, Thind IS (1971) Protection against West Nile virus induced by a previous injection with dengue virus. Am J Epidemiol 94:596–606CrossRefPubMed
2.
Zurück zum Zitat Price WH, Thind IS, O’Leary W, El Dadah AH (1967) A protective mechanism induced by live group B arboviruses against heterologous group B arboviruses independent of serum neutralizing antibodies or interferon. Am J Epidemiol 86:11–27CrossRefPubMed Price WH, Thind IS, O’Leary W, El Dadah AH (1967) A protective mechanism induced by live group B arboviruses against heterologous group B arboviruses independent of serum neutralizing antibodies or interferon. Am J Epidemiol 86:11–27CrossRefPubMed
3.
Zurück zum Zitat Sather GE, Hammon MW (1970) Protection against St. Louis encephalitis and West Nile arboviruses by previous dengue virus (types 1-4) infection. Proceedings Society Experimental Biology Medicine 135:573–578CrossRef Sather GE, Hammon MW (1970) Protection against St. Louis encephalitis and West Nile arboviruses by previous dengue virus (types 1-4) infection. Proceedings Society Experimental Biology Medicine 135:573–578CrossRef
5.
Zurück zum Zitat Tarr GC, Hammon WM (1974) Cross-protection between group B arboviruses: resistance in mice to Japanese B encephalitis and St. Louis encephalitis viruses induced by dengue virus immunization. Infect Immun 9:909–915PubMedPubMedCentral Tarr GC, Hammon WM (1974) Cross-protection between group B arboviruses: resistance in mice to Japanese B encephalitis and St. Louis encephalitis viruses induced by dengue virus immunization. Infect Immun 9:909–915PubMedPubMedCentral
6.
Zurück zum Zitat Libraty DH, Nisalak A, Endy TP, Suntayakorn S, Vaughn DW, Innis BL (2002) Clinical and immunological risk factors for severe disease in Japanese encephalitis. Transactions Royal Society Tropical Medicine Hygeine 96:173–178CrossRef Libraty DH, Nisalak A, Endy TP, Suntayakorn S, Vaughn DW, Innis BL (2002) Clinical and immunological risk factors for severe disease in Japanese encephalitis. Transactions Royal Society Tropical Medicine Hygeine 96:173–178CrossRef
7.
Zurück zum Zitat Halstead SB, O’Rourke EJ (1977) Antibody-enhanced dengue virus infection in primate leukocytes. Nature 265:739–741CrossRefPubMed Halstead SB, O’Rourke EJ (1977) Antibody-enhanced dengue virus infection in primate leukocytes. Nature 265:739–741CrossRefPubMed
8.
Zurück zum Zitat Halstead SB, Porterfield JS, O’Rourke EJ (1980) Enhancement of dengue virus infection in monocytes by flavivirus antisera. Am J Tropical Medicine Hygeine 29:638–642CrossRef Halstead SB, Porterfield JS, O’Rourke EJ (1980) Enhancement of dengue virus infection in monocytes by flavivirus antisera. Am J Tropical Medicine Hygeine 29:638–642CrossRef
9.
Zurück zum Zitat Halstead SB, Nimmannitya S, Cohen SN (1970) Observations related to pathogenesis of dengue hemorrhagic fever. IV Relation Disease Severity Antibody Response Virus Recovered Yale J Biology Medicine 42:311–328 Halstead SB, Nimmannitya S, Cohen SN (1970) Observations related to pathogenesis of dengue hemorrhagic fever. IV Relation Disease Severity Antibody Response Virus Recovered Yale J Biology Medicine 42:311–328
10.
Zurück zum Zitat Anderson KB, Gibbons RV (2011) Thomas SJ, et al preexisting Japanese encephalitis virus neutralizing antibodies and increased symptomatic dengue illness in a school-based cohort in Thailand. PLoS Neglected Tropical Disease 5:e1311CrossRef Anderson KB, Gibbons RV (2011) Thomas SJ, et al preexisting Japanese encephalitis virus neutralizing antibodies and increased symptomatic dengue illness in a school-based cohort in Thailand. PLoS Neglected Tropical Disease 5:e1311CrossRef
11.
Zurück zum Zitat Sato R, Hamada N, Kashiwagi T, Imamura Y, Hara K, Naito Y et al (2015) Dengue hemorrhagic fever in a Japanese traveler who had preexisting Japanese encephalitis virus antibody. Tropical Medicine Health 43:85–88CrossRefPubMedPubMedCentral Sato R, Hamada N, Kashiwagi T, Imamura Y, Hara K, Naito Y et al (2015) Dengue hemorrhagic fever in a Japanese traveler who had preexisting Japanese encephalitis virus antibody. Tropical Medicine Health 43:85–88CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Gadkari DA, Shaikh BH (1984) IgM antibody capture ELISA in the diagnosis of Japanese encephalitis, West Nile & dengue virus infections. Indian J Med Res 80:613–619PubMed Gadkari DA, Shaikh BH (1984) IgM antibody capture ELISA in the diagnosis of Japanese encephalitis, West Nile & dengue virus infections. Indian J Med Res 80:613–619PubMed
14.
Zurück zum Zitat Jennett B, Bond M (1975) Assessment of outcome after severe brain damage. Lancet 1(7905):480–484CrossRefPubMed Jennett B, Bond M (1975) Assessment of outcome after severe brain damage. Lancet 1(7905):480–484CrossRefPubMed
15.
Zurück zum Zitat Nuegoonpipat A-A, Panthuyosri N, Anantapreecha S, Chanama S, Sa-Ngasang A, Sawanpanyalert P, Kurane I (2008) Cross-reactive IgM responses in patients with dengue or Japanese encephalitis. J Clin Virol 42:75–77CrossRef Nuegoonpipat A-A, Panthuyosri N, Anantapreecha S, Chanama S, Sa-Ngasang A, Sawanpanyalert P, Kurane I (2008) Cross-reactive IgM responses in patients with dengue or Japanese encephalitis. J Clin Virol 42:75–77CrossRef
16.
Zurück zum Zitat Pipattanaboon C, Sasaki T, Nishimura M, Setthapramote C, Pitaksajjakul P, Leaungwutiwong P et al (2013) Cross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with Japanese encephalitis virus. Biologics 7:175–187PubMedPubMedCentral Pipattanaboon C, Sasaki T, Nishimura M, Setthapramote C, Pitaksajjakul P, Leaungwutiwong P et al (2013) Cross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with Japanese encephalitis virus. Biologics 7:175–187PubMedPubMedCentral
17.
Zurück zum Zitat Saito Y, Moi ML, Takeshita N, Lim KC, Shiba H, Hosono K, Saijo M, Kurane I, Takasaki T (2016) Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults. BMC Infect Dis 16:578CrossRefPubMedPubMedCentral Saito Y, Moi ML, Takeshita N, Lim KC, Shiba H, Hosono K, Saijo M, Kurane I, Takasaki T (2016) Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults. BMC Infect Dis 16:578CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Stiasny K, Kiermayr S, Holzmann H, Heinz FX (2006) Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites. J Virol 80:9557–9568CrossRefPubMedPubMedCentral Stiasny K, Kiermayr S, Holzmann H, Heinz FX (2006) Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites. J Virol 80:9557–9568CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Crill WD, Trainor NB, Chang GJ (2007) A detailed mutagenesis study of flavivirus cross-reactive epitopes using West Nile virus-like particles. J Gen Virol 88:1169–1174CrossRefPubMed Crill WD, Trainor NB, Chang GJ (2007) A detailed mutagenesis study of flavivirus cross-reactive epitopes using West Nile virus-like particles. J Gen Virol 88:1169–1174CrossRefPubMed
22.
Zurück zum Zitat Trainor NB, Crill WD, Roberson JA, Chang GJ (2007) Mutation analysis of the fusion domain region of St. Louis encephalitis virus envelope protein. Virology 360:398–406CrossRefPubMed Trainor NB, Crill WD, Roberson JA, Chang GJ (2007) Mutation analysis of the fusion domain region of St. Louis encephalitis virus envelope protein. Virology 360:398–406CrossRefPubMed
23.
Zurück zum Zitat Lai CY et al (2008) Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II. J Virol 82:6631–6643CrossRefPubMedPubMedCentral Lai CY et al (2008) Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II. J Virol 82:6631–6643CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Dejnirattisai W et al (2010) Cross-reacting antibodies enhance dengue virus infection in humans. Science 328:745–748CrossRefPubMed Dejnirattisai W et al (2010) Cross-reacting antibodies enhance dengue virus infection in humans. Science 328:745–748CrossRefPubMed
Metadaten
Titel
Effect of prior dengue infection on severity and outcome of Japanese encephalitis
verfasst von
A. Verma
A. Jain
C. Kumar
M. Agarwal
R. Kumar
Publikationsdatum
06.02.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 3/2018
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-018-3207-9

Weitere Artikel der Ausgabe 3/2018

European Journal of Clinical Microbiology & Infectious Diseases 3/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

VHF-Ablation nützt wohl nur bei reduzierter Auswurfleistung

02.05.2024 Ablationstherapie Nachrichten

Ob die Katheterablation von Vorhofflimmern bei Patienten mit Herzinsuffizienz die Komplikationsraten senkt, scheint davon abzuhängen, ob die Auswurfleistung erhalten ist oder nicht. Das legen die Ergebnisse einer Metaanalyse nahe.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.